CANF Can-Fite BioPharma Ltd. ADRs

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:CFBI.

$0.85  -0.02 (-2.20%)
As of 08/08/2022 11:34:33 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  11/01/2012
Outstanding shares:  27,191,543
Average volume:  154,340
Market cap:   $23,014,922
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -1.55
PB ratio:   1.60
PS ratio:   26.98
Return on equity:   -87.71%
Net income %:   -1,478.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy